Skip to main content
NexImmune, Inc.Portfolio

NexImmune Strengthens Scientific Leadership by Appointing Jerome Zeldis as EVP R&D and Jeffrey Weber as Chief Scientific Advisor

By January 4, 2021March 25th, 2021No Comments

NexImmune Inc.

  • Zeldis formerly served as Celgene CMO and CEO of Celgene Global Health
  • Weber is a renowned melanoma specialist and leading immunotherapy translational and clinical scientist
  • Both will help NexImmune advance current early-stage clinical trials and will guide Company’s translational efforts to develop new immunotherapy products